long-term safety and efficacy of sutimlimab for chronic itp
Published 3 years ago • 1.2K plays • Length 4:14Download video MP4
Download video MP3
Similar videos
-
1:24
the long-term safety and efficacy of ibrutinib monotherapy in patients with previously-treated wm
-
3:02
real-world analysis of safety and efficacy of romiplostim for itp
-
2:36
safety and preliminary efficacy of elotuzumab and belantamab mafodotin in patients with r/r myeloma
-
1:15
the safety and efficacy of peritransplantation ruxolitinib in patients with mf
-
2:41
safety and efficacy of actaly-cel™ in r/r pediatric b-all
-
3:15
long-term risks associated with persistent isolated mild thrombocytopenia
-
2:25
the safety & efficacy of copanlisib nivolumab in patients with rt and tnhl: a chemo-free approach
-
2:15
safety and efficacy of astx727 in patients with cmml from phase ii and phase iii ascertain studies
-
3:03
understanding immune thrombocytopenia: perspectives in itp
-
39:32
how to improve medication safety in hospitals and pharmacies
-
59:12
strike first: strengthen your ibm i security against ransomware
-
1:09
emerging treatment options for refractory immune thrombocytopenia
-
1:32
phase ii efficacy and safety results of ruxolitinib for patients with symptomatic cmml
-
1:32
shifting the treatment landscape of itp: novel agents and future outlooks
-
4:02
elm-2: promising safety and efficacy of odronextamab in r/r dlbcl
-
1:55
phase i/ib safety study of prgn-3006 ultracar-t in patients with r/r cd33-positive aml & hr-mds
-
3:52
a phase ii study evaluating the safety and efficacy of olutasidenib in patients with r/r midh1 aml
-
1:31
risk-adjusted safety analysis of pacritinib for patients with mf
-
5:45
advance iv results: efficacy and safety of intravenous efgartigimod in adults with primary itp
-
3:54
impact of long-term immunosuppressive therapy
-
2:07
analysis of long-term exposure to momelotinib in the phase iii simplfy myelofibrosis trials
-
1:33
novel treatments for cold agglutinin disease